Publicaciones (159) Publicaciones de David Manuel Castro Díaz

2024

  1. Consensus update on the therapeutic approach to patients with neurogenic detrusor overactivity

    Actas Urologicas Espanolas, Vol. 48, Núm. 9, pp. 674-682

  2. Editorial for the Abstracts of the 21st Meeting of the Association of Academic European Urologists [European Urology Open Science 2024;60 (Suppl 1):S1-39]

    European Urology Open Science

  3. Management of Colovesical Fistulae: The Updated Evidence

    Current Bladder Dysfunction Reports, Vol. 19, Núm. 2, pp. 165-170

  4. Position of the Ibero-American Society of Neurourology and Urogynecology (SINUG) on the urodynamics (UDS) in women undergoing surgical treatment for stress urinary incontinence (SUI)

    Continence, Vol. 12

  5. Summary of the 2024 Update of the European Association of Urology Guidelines on Neurourology

    European Urology, Vol. 85, Núm. 6, pp. 543-555

2023

  1. Bladder Capacity in Women With Overactive Bladder Syndrome: A Cross-sectional Study

    Urology, Vol. 179, pp. 44-49

  2. Complications of Synthetic Midurethral Slings: Is There a Relevant Discrepancy Between Observational Data and Clinical Trials?

    European Urology Focus

  3. Innovative training modality for sacral neuromodulation (SNM): Patient-specific computerized tomography (CT) reconstructed 3D-printed training system: ICS School of Modern Technology novel training modality

    Neurourology and Urodynamics, Vol. 42, Núm. 1, pp. 297-302

  4. Long-Term Functional Outcomes and Quality of Life after Male Transobturator-Retrourethral Sling Surgery

    Urologia Internationalis, Vol. 107, Núm. 3, pp. 304-309

  5. Management of Acute Cystitis in the Era of COVID-19

    Current Bladder Dysfunction Reports, Vol. 18, Núm. 1, pp. 10-15

2022

  1. Artificial Urinary Sphincter in a High-Risk Urethra: Transcorporal Gullwing Modification Description of the Technique

    Turkish Journal of Urology, Vol. 48, Núm. 6, pp. 460-464

  2. BOTULINUM TOXIN, TREATMENT OPTION FOR NEUROGENIC DETRUSOR OVERACTIVITY

    Farmacia, Vol. 70, Núm. 2, pp. 198-203

  3. Corrigendum re "Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex" [Eur Urol Focus 2020;6:522-30

    European urology focus

  4. Current role of neuromodulation in bladder pain syndrome/interstitial cystitis

    Therapeutic Advances in Urology, Vol. 14

  5. Definitions of Urinary Tract Infection Used in Interventional Studies Involving Neurourological Patients—A Systematic Review

    European Urology Focus, Vol. 8, Núm. 5, pp. 1386-1398

  6. Efficacy and Safety of Surgical Treatments for Neurogenic Stress Urinary Incontinence in Adults: A Systematic Review

    European Urology Focus, Vol. 8, Núm. 4, pp. 1090-1102

  7. Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  8. Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study

    Journal of Clinical Medicine, Vol. 11, Núm. 13

  9. Female Urethroplasty: Anterior Vaginal Wall Flap (Blandy Flap) - Simpler Tends to Be Better

    Urologia Internationalis, Vol. 106, Núm. 3, pp. 313-316

  10. Is the first day of the bladder diary enough for symptom assessment in women with lower urinary tract symptoms?

    Continence, Vol. 2